SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
271Erik: >> Friday, August 20, 2004 << just in case you hadn't noscaram(o)uche-8/29/2004
270Cell Therapeutics says it "likely" promoted drug for unapproved uses Icebrg-8/29/2004
269WRH managed CTIC's recent share offering. M2Mao II-8/11/2004
268WRH: INITIATING COVERAGE WITH A BUY RATING: ROBUST PIPELINE, COMMERCI 2004-08-10mopgcw-8/11/2004
267Probably the latter, in light of the recent offering. Tonic for the troops, viatuck-8/10/2004
266BB Biotech drops below 5%. I didn't check to see if they had sold anything,scaram(o)uche-8/4/2004
265Odd that they would try arsenic trioxide only as a single agent in the neuroblastuck-7/29/2004
264And just for good order. These are the remaining trials the company is or is plaIcebrg-7/29/2004
263Well, what can a poor company do? Apart from having the CEO travelling around inIcebrg-7/29/2004
262OK, point made. However, I keep finding interesting stuff about arsenic trioxidtuck-7/29/2004
261Cell Therapeutics Adds To Cash With $42.8M Offering There is some commentary frIcebrg-7/29/2004
260I was pleasantly surprised. Ticked off, but pleasantly surprised by the positivscaram(o)uche-7/28/2004
259true, but in a gaggle-like fashion when they do hit. a very good sign, but one scaram(o)uche-7/28/2004
258and an unusual one, in my experience.....tom pope-7/28/2004
257Hey - maybe they are boosting the morale of patients involved in the trial by ofBiomaven-7/28/2004
256>>Hey, you reckon Bianco might be spotted on commercial flights now?>&gIcebrg-7/28/2004
255>>trim some administrative and travel costs<< Hey, you reckon Bianctuck-7/28/2004
254Cell Therapeutics slashing expenses to stem red ink By Luke Timmerman Seattle TIcebrg-7/28/2004
253>>Having missed the good window, I wonder if CTIC can't wait until theIcebrg-7/28/2004
252The problem I have with the Stellar 3 results is that they are almost too good tIcebrg-7/27/2004
251Thanks, Erik, your comments on the Stellar trials are helpful. I favor the treatuck-7/27/2004
250>>Desite the trumpeting about the record Trisenox revenues, analysts estimIcebrg-7/27/2004
249>>SEATTLE, July 27 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)tuck-7/27/2004
248Cell Therapeutics, Inc. Completes Enrollment in Third Pivotal Trial of XYOTAX(TMnigel bates-7/26/2004
247J Neurol Sci. 2004 Aug 15;223(1):81-6. Pixantrone (BBR2778): a new immunosuppscaram(o)uche-7/22/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News